These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 28934968)

  • 1. Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis.
    Yamashita H; Ishihara S; Nozawa H; Kawai K; Kiyomatsu T; Okuma K; Abe O; Watanabe T; Nakagawa K
    Radiat Oncol; 2017 Sep; 12(1):156. PubMed ID: 28934968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Short-term efficacy comparison between preoperative three dimensional conformal radiotherapy and volumetric modulated arc therapy concurrently combined with chemotherapy in the treatment of locally advanced rectal carcinoma].
    Xiao L; Yu X; Zhu Y; Xiao W; Zeng Z; Liu M; Zhang R; Gao Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jul; 19(7):769-75. PubMed ID: 27452754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moderate dose escalation with volumetric modulated arc therapy improves outcome in rectal cancer.
    Stuyck C; Wegge M; Bulens P; Joye I; Haustermans K
    Acta Oncol; 2017 Nov; 56(11):1501-1506. PubMed ID: 28826304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer.
    Cilla S; Caravatta L; Picardi V; Sabatino D; Macchia G; Digesù C; Deodato F; Massaccesi M; De Spirito M; Piermattei A; Morganti AG
    Clin Oncol (R Coll Radiol); 2012 May; 24(4):261-8. PubMed ID: 21820294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study.
    Picardi V; Macchia G; Guido A; Giaccherini L; Deodato F; Farioli A; Cilla S; Compagnone G; Ardizzoni A; Cuicchi D; Gambacorta MA; Cellini F; Frezza G; Poggioli G; Valentini V; Fuccio L; Morganti AG
    Clin Colorectal Cancer; 2017 Mar; 16(1):16-22. PubMed ID: 27435759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison.
    Macchia G; Cilla S; Morganti AG; Deodato F; Legge F; Piermattei A; Chiantera V; Scambia G; Valentini V; Ferrandina G
    Acta Oncol; 2014 Feb; 53(2):251-8. PubMed ID: 24050516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3D conformal radiotherapy or VMAT.
    Münch S; Aichmeier S; Hapfelmeier A; Duma MN; Oechsner M; Feith M; Combs SE; Habermehl D
    Strahlenther Onkol; 2016 Oct; 192(10):722-9. PubMed ID: 27418129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative Volumetric Modulated Arc Therapy With Simultaneous Integrated Boost for Locally Advanced Distal Rectal Cancer.
    Yang Y; Liu Q; Jia B; Du X; Dai G; Liu H; Chen J; Zeng M; Wen K; Zhu Y; Wang Y; Feng L
    Technol Cancer Res Treat; 2019 Jan; 18():1533033818824367. PubMed ID: 30803368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases.
    Cilla S; Deodato F; Digesù C; Macchia G; Picardi V; Ferro M; Sallustio G; De Spirito M; Piermattei A; Morganti AG
    Med Dosim; 2014; 39(1):108-16. PubMed ID: 24342167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric comparison between three-dimensional conformal radiotherapy followed by electron beam boost and volumetric modulated arc therapy using concomitant boost for the heart and cardiac segments in patients with left-sided breast cancer at risk for radiation-induced cardiac toxicity.
    Murakami Y; Murakami Y; Kamima T; Oguchi M; Abo N; Takahashi T; Kaneko M; Nakano M; Matsubayashi F; Harada A; Taguchi S; Hashimoto T; Yoshioka Y
    Phys Med; 2022 Mar; 95():126-132. PubMed ID: 35158316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of preoperative helical tomotherapy with a simultaneous integrated boost for rectal cancer.
    Engels B; Tournel K; Everaert H; Hoorens A; Sermeus A; Christian N; Storme G; Verellen D; De Ridder M
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):142-8. PubMed ID: 22014952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced techniques in neoadjuvant radiotherapy allow dose escalation without increased dose to the organs at risk : Planning study in esophageal carcinoma.
    Fakhrian K; Oechsner M; Kampfer S; Schuster T; Molls M; Geinitz H
    Strahlenther Onkol; 2013 Apr; 189(4):293-300. PubMed ID: 23443611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced toxicity in the treatment of locally advanced rectal cancer: a comparison of volumetric modulated arc therapy and 3D conformal radiotherapy.
    Dröge LH; Weber HE; Guhlich M; Leu M; Conradi LC; Gaedcke J; Hennies S; Herrmann MK; Rave-Fränk M; Wolff HA
    BMC Cancer; 2015 Oct; 15():750. PubMed ID: 26486986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dosimetric comparison of 3D conformal vs intensity modulated vs volumetric arc radiation therapy for muscle invasive bladder cancer.
    Foroudi F; Wilson L; Bressel M; Haworth A; Hornby C; Pham D; Cramb J; Gill S; Tai KH; Kron T
    Radiat Oncol; 2012 Jul; 7():111. PubMed ID: 22824133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of relatively low neoadjuvant radiation doses for locally advanced rectal cancer: A propensity score-matched analysis.
    Ye W; Shi L; Qian L; Sun Y; Sun X
    Cancer Rep (Hoboken); 2019 Oct; 2(5):e1188. PubMed ID: 32721108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of left sided breast cancer for a patient with funnel chest: volumetric-modulated arc therapy vs. 3D-CRT and intensity-modulated radiotherapy.
    Haertl PM; Pohl F; Weidner K; Groeger C; Koelbl O; Dobler B
    Med Dosim; 2013; 38(1):1-4. PubMed ID: 22727550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of radiotherapy treatment planning techniques in patients with rectal cancers by analyzing testes doses.
    Duman E; Bilek Y; Ceyran G
    J Cancer Res Ther; 2021; 17(1):56-61. PubMed ID: 33723133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase II study of preoperative chemoradiation with tegafur-uracil plus leucovorin for locally advanced rectal cancer with pharmacogenetic analysis.
    Kim SY; Baek JY; Oh JH; Park SC; Sohn DK; Kim MJ; Chang HJ; Kong SY; Kim DY
    Radiat Oncol; 2017 Mar; 12(1):62. PubMed ID: 28347333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced acute bowel toxicity in patients treated with intensity-modulated radiotherapy for rectal cancer.
    Samuelian JM; Callister MD; Ashman JB; Young-Fadok TM; Borad MJ; Gunderson LL
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1981-7. PubMed ID: 21477938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the application among intensity-modulated radiotherapy, 3D-conformal radiotherapy and conventional radiotherapy for locally advanced middle-low rectal cancer].
    Zhang C; Dong J; Shen T; Li Y; Yang Z; Cheng X; Luo H; Yang J; Shi Z; Wang W; Zhang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Dec; 21(12):1414-1420. PubMed ID: 30588595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.